RESEARCH PAPER
Predictors of mortality among a cohort of HIV/AIDS patients on anti-retroviral therapy in coastal South India
More details
Hide details
Submission date: 2016-06-17
Final revision date: 2016-08-13
Acceptance date: 2016-11-01
Publication date: 2017-01-17
HIV & AIDS Review 2017;16(1):18-23
KEYWORDS
TOPICS
ABSTRACT
Introduction: As the number of patients on anti-retroviral therapy (ART) rises, it is important to identify factors that predict mortality among these patients so that they can be closely monitored. Aim of the study was to determine the mortality rate among a cohort of HIV patients on naïve ART and to assess the predictors of mortality among them.
Material and methods: In this retrospective study, records of 249 patients living with HIV (PLHIV) who were ART naïve, enrolled in the ART centre attached to Kasturba Medical College Hospital, Mangalore from February 2012 to February 2015, were analysed. Univariate and multivariate logistic regression was carried out to assess the factors predicting mortality among these patients.
Results: By the end of the study period, 47 out of 249 patients died, giving an overall mortality rate of 18.8%. The mean age of the PLHIV was 43.4 ± 9.1 years. WHO stage 3/4 disease was present in 47.4% of patients. On univariate analysis, mortality was found to be significantly associated with alcohol consumption, being non-ambulatory, underweight (body mass index [BMI] < 18.5 kg/m2), WHO stage 3 or 4 disease, presence of opportunistic infections (OIs), presence of tuberculosis, being on an efavirenz-based regimen, poor adherence (< 95%), CD4 count < 350 cells/mm3, anaemia and raised creatinine levels. However, on multivariate analysis, presence of OIs and low BMI were found to independently predict mortality.
Conclusions: Our study identifies lower BMI and presence of OIs as independent risk factors predicting mortality.
REFERENCES (29)
2.
National AIDS Control Organization. Number of PLHIV alive and on ART at the end of September 2014. Retrieved from:
http://www.naco.gov.in/upload/... %20September%202014.pdf (2014).
5.
Department of AIDS Control. Ministry of Health & Family Welfare. Government of India. Annual Report 2013-14. Retrieved from:
http://www.naco.gov.in/upload/... (2014).
6.
Mageda K, Leyna GH, Mmbaga EJ. High Initial HIV/AIDS-related mortality and-its predictors among patients on antiretroviral therapy in the Kagera Region of Tanzania: a five-year retrospective cohort study. AIDS Res Treat 2012; 2012: 843598.
7.
Department of AIDS Control. National AIDS Control Organization, Ministry of Health & Family Welfare. Government of India. Anti-Retroviral Therapy guidelines for HIV infected Adults and Adolescents 2013. Retrieved from:
http://www.naco.gov.in/upload/... (2013).
8.
World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Retrieved from:
http://www.who.int/hiv/pub/gui... (2007).
9.
Poda A, Hema A, Zoungrana J, et al. Mortality of HIV-Infected Patients on Antiretroviral Therapy in a Large Public Cohort in West Africa, Burkina Faso: Frequency and Associated Factors. Adv Infect Dis 2013; 3: 281-289.
10.
Tadesse K, Haile F, Hiruy N. Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum Hospital, Northern Ethiopia: a retrospective cohort study. PLoS One 2014; 9: e87392.
11.
Eguzo KN, Lawal AK, Eseigbe CE, et al. Determinants of Mortality among Adult HIV-Infected Patients on Antiretroviral Therapy in a Rural Hospital in South-Eastern Nigeria: A 5-Year Cohort Study. AIDS Res Treat 2014; 867827.
12.
Mangili A, Murman DH, Zampini AM, et al. Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort. Clin Infect Dis 2006; 42: 836-842.
13.
Duggal S, Chugh TD, Duggal AK, et al. HIV and malnutrition: effects on immune system. Clin Dev Immunol 2012; 2012: 784740.
14.
Kouanda S, Meda IB, Nikiema L, et al. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care 2012; 24: 478-490.
15.
Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther 2012; 9: 15.
16.
Liu E, Spiegelman D, Semu H, et al. Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania. J Infect Dis 2011; 204: 282-290.
17.
De Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. Food Nutr Bull 2010; 31: S313-S344.
18.
New York State Department of Health AIDS Institute, Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-infected patients (2009). Retrieved from:
http://cdn.hivguidelines.org/w... Reconstitution-Inflammatory.pdf.
19.
Kumarasamy N, Vallabhaneni S, Flanigan TP, et al. Clinical profile of HIV in India. Indian J Med Res 2005; 121: 377-394. Retrieved from:
http://icmr.nic.in/ijmr/2005/a....
20.
Ghate M, Deshpande S, Tripathy S, et al. Mortality in HIV infected individuals in Pune, India. Indian J Med Res 2011; 133: 414-420.
21.
Bhowmik A, Bhandari S, De R, et al. Predictors of mortality among HIV-infected patients initiating anti-retroviral therapy at a tertiary care hospital in eastern India. Asian Pac J Trop Med 2012; 5: 986-990.
22.
Alvarez-Uria G, Naik PK, Pakam R, et al. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action 2013; 6: 21682.
23.
Javalkar P, Prakash R, Isac S, et al. An Estimation of Mortality Risks among People Living with HIV in Karnataka State, India: Learnings from an Intensive HIV/AIDS Care and Support Programme. PLoS One 2016; 11: e0156611.
24.
Zhyvytsia D. Mortality and its predictors among highly active antiretroviral therapy naive HIV-infected individuals: data from prospective cohort study in Ukraine. Georgian Med News 2014; 232-233: 69-74.
25.
Ojikutu BO, Zheng H, Walensky RP, et al. Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S Afr Med J 2008; 98: 204-208.
26.
Fregonese F, Collins IJ, Jourdain G, et al. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr 2012; 60: 91-98.
28.
Hambisa MT, Ali A, Dessie Y. Determinants of mortality among HIV positives after initiating antiretroviral therapy in Western Ethiopia: a hospital-based retrospective cohort study. ISRN AIDS 2013; 2013: 491601.
29.
Focà E, Odolini S, Sulis G, et al. Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa. BMC Infect Dis 2014; 14: 153.